Moderna, Inc. Europe revenue
Europe revenue at Moderna, Inc. came to $53.0M for the fiscal year to 31 Dec 2025, down 91.1% from a year earlier.
As Moderna, Inc. reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 20 Feb 2026.
By fiscal year
| Period ending | Europe revenue | Change on a year | Filed |
|---|---|---|---|
| 31 Dec 2025 | $53.0M | down 91.1% | 20 Feb 2026 |
| 31 Dec 2024 | $598.0M | down 55.9% | 21 Feb 2025 |
| 31 Dec 2023 | $1.4B | down 80.1% | 23 Feb 2024 |
| 31 Dec 2022 | $6.8B | down 0.5% | 24 Feb 2023 |
| 31 Dec 2021 | $6.8B | — | 25 Feb 2022 |
| 31 Dec 2020 | $33.0M | up 560.0% | 26 Feb 2021 |
| 31 Dec 2019 | $5.0M | — | 27 Feb 2020 |
Definition
Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.
Other operating KPIs of Moderna, Inc.: COVID revenue · Stand-ready manufacturing revenue · RSV revenue · Collaboration Arrangement, Including Arrangements With Affiliate revenue · Grant revenue · United States revenue · Rest of world revenue · financial statements
Every KPI and segment of MRNA, in the terminal.
Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.
